CTOs on the Move

Ginger

www.ginger.com

 
When Ginger co-founder and COO, Karan Singh, was young, his mother would brew him ginger tea when she could sense that he was about to get sick. A preventative health remedy that originates from Southeast Asia, the ginger root is commonly used at the first sign of illness, before things get worse. Similar to this approach, the Ginger system takes a preventative approach to mental health, addressing issues before they evolve into greater challenges and providing support anywhere, at any time. By bringing the power of on-demand mental health support to hundreds of thousands of people globally, we continue to ...
  • Number of Employees: 250-1000
  • Annual Revenue: $0-1 Million
  • www.ginger.com
  • 116 New Montgomery St 5th Floor
    San Francisco, CA USA 94105
  • Phone: N/A

Executives

Name Title Contact Details

Funding

Ginger raised $100M on 03/23/2021

Similar Companies

OPCO Laboratory Inc

OPCO Laboratory Inc is a Fitchburg, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AQ Safety

AQ Safety is a Albuquerque, NM-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Austills Rehabilitation Services

Austill's specializes in providing pediatric therapy services to School Districts, Early Intervention Programs, and County-Wide Regional Special Education providers. Since 1984, Austill's has provided therapy for educational programs. We customize all

Dermatologists of Central States

DOCS Dermatologists of Central States is one of the largest dermatology practice groups in the United States. With over 155 providers spread across seven central states, we have been serving patients for over 40 years. Our focus is on medical, surgical...

Celator Pharmaceuticals

Celator Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that is transforming the science of combination therapy and developing products to improve outcomes for patients with cancer. The Company is working to establish a new treatment paradigm in which rationally-designed, fully-integrated combination products replace combination regimens of individual agents. Celator`s proprietary technology platform, CombiPlex®, identifies the most effective synergistic ratio of the component drugs, optimizes the pharmacology of the drug combination prior to human clinical trials, allows simultaneous administration of the components as a single product and maintains the synergistic ratio of the components after administration thereby exposing tumor cells to the right amounts of drug for the right length of time.